N/A N=148 Randomized Single-blind Health Services Research

Healthy, Immunized Communities Study

Vaccine Hesitancy · Communicable Diseases in Children

Bottom Line

View on ClinicalTrials.gov: NCT03854734 ↗

Enrolled (actual)

148

Serious AEs

—

Results posted

Jul 2024

Primary outcome: Primary: Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV) — 74.3; 83.3; 97.9; 93.0 percentage of participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Community Event (Behavioral); Educational Material (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Milton S. Hershey Medical Center
Primary completion: Feb 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Participants With Intent to Vaccinate Adolescent Child (Tdap, MCV, HPV)	74.3; 83.3; 97.9; 93.0; 72.9; 80.5	—

Summary

This project aims to understand how improving vaccine education and awareness can impact the number of parents who vaccinate, or intend to vaccine, their middle school-aged children with age-appropriate vaccines, including human papillomavirus (HPV), meningitis (MCV) and tetanus, diphtheria, pertussis (TDap).

Eligibility Criteria

Inclusion Criteria

18 years or older
Parents and guardians of children who attend a School District of Lancaster middle schools
Individuals who read and understand English
Individuals with an email address

Exclusion Criteria

Individuals who are non-English speaking
Parents/Guardians <18 years or older who do not have children attending a middle school in the School District of Lancaster
Individuals who do not have an email address
Individuals who plan on moving out of the Lancaster City area in the next year

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03854734). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.